OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults
Xuyang Tang, Abha Sharma, Maria Pasic, et al.
JAMA Network Open (2022) Vol. 5, Iss. 2, pp. e2146798-e2146798
Open Access | Times Cited: 28
Xuyang Tang, Abha Sharma, Maria Pasic, et al.
JAMA Network Open (2022) Vol. 5, Iss. 2, pp. e2146798-e2146798
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination
Karen Colwill, Yannick Galipeau, Matthew Stuible, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 3
Open Access | Times Cited: 105
Karen Colwill, Yannick Galipeau, Matthew Stuible, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 3
Open Access | Times Cited: 105
Age-stratified infection fatality rate of COVID-19 in the non-elderly population
Angelo Maria Pezzullo, Cathrine Axfors, Despina G. Contopoulos‐Ioannidis, et al.
Environmental Research (2022) Vol. 216, pp. 114655-114655
Open Access | Times Cited: 95
Angelo Maria Pezzullo, Cathrine Axfors, Despina G. Contopoulos‐Ioannidis, et al.
Environmental Research (2022) Vol. 216, pp. 114655-114655
Open Access | Times Cited: 95
Modelling COVID-19 in the North American region with a metapopulation network and Kalman filter
Matteo Perini, Teresa K. Yamana, Marta Galanti, et al.
Epidemics (2025), pp. 100818-100818
Open Access
Matteo Perini, Teresa K. Yamana, Marta Galanti, et al.
Epidemics (2025), pp. 100818-100818
Open Access
Omicron BA.1/1.1 SARS-CoV-2 Infection among Vaccinated Canadian Adults
Patrick Brown, Sze Hang Fu, Aiyush Bansal, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 24, pp. 2337-2339
Open Access | Times Cited: 26
Patrick Brown, Sze Hang Fu, Aiyush Bansal, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 24, pp. 2337-2339
Open Access | Times Cited: 26
Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health
Sheila F. OʼBrien, Niamh Caffrey, Qilong Yi, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Sheila F. OʼBrien, Niamh Caffrey, Qilong Yi, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Differential COVID-19 infection rates in children, adults, and elderly: Systematic review and meta-analysis of 38 pre-vaccination national seroprevalence studies
Cathrine Axfors, Angelo Maria Pezzullo, Despina G. Contopoulos‐Ioannidis, et al.
Journal of Global Health (2023) Vol. 13
Open Access | Times Cited: 12
Cathrine Axfors, Angelo Maria Pezzullo, Despina G. Contopoulos‐Ioannidis, et al.
Journal of Global Health (2023) Vol. 13
Open Access | Times Cited: 12
Anti–SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021–June 2022
Kelsey M. Sumner, Ruchi Yadav, Emma K. Noble, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 1, pp. 45-54
Open Access | Times Cited: 3
Kelsey M. Sumner, Ruchi Yadav, Emma K. Noble, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 1, pp. 45-54
Open Access | Times Cited: 3
The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study
N. Almeida, Ian Schiller, Danbing Ke, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
N. Almeida, Ian Schiller, Danbing Ke, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Seropositivity and risk factors for SARS-CoV-2 infection in a South Asian community in Ontario: a cross-sectional analysis of a prospective cohort study
Sonia S. Anand, Corey Arnold, Shrikant I. Bangdiwala, et al.
CMAJ Open (2022) Vol. 10, Iss. 3, pp. E599-E609
Open Access | Times Cited: 10
Sonia S. Anand, Corey Arnold, Shrikant I. Bangdiwala, et al.
CMAJ Open (2022) Vol. 10, Iss. 3, pp. E599-E609
Open Access | Times Cited: 10
Hybrid immunity from severe acute respiratory syndrome coronavirus 2 infection and vaccination in Canadian adults: A cohort study
Patrick Brown, Sze Hang Fu, Leslie Newcombe, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 1
Patrick Brown, Sze Hang Fu, Leslie Newcombe, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 1
A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination
Karen Colwill, Yannick Galipeau, Matthew Stuible, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 10
Karen Colwill, Yannick Galipeau, Matthew Stuible, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 10
Seroprevalence of SARS-CoV-2 antibodies among blood donors in Québec: an update from a serial cross-sectional study
Antoine Lewin, Gaston De Serres, Yves Grégoire, et al.
Can J Public Health (2022) Vol. 113, Iss. 3, pp. 385-393
Open Access | Times Cited: 6
Antoine Lewin, Gaston De Serres, Yves Grégoire, et al.
Can J Public Health (2022) Vol. 113, Iss. 3, pp. 385-393
Open Access | Times Cited: 6
A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021
Kento T. Abe, Bhavisha Rathod, Karen Colwill, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 5
Kento T. Abe, Bhavisha Rathod, Karen Colwill, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 5
Age-stratified infection fatality rate of COVID-19 in the non-elderly informed from pre-vaccination national seroprevalence studies
Angelo Maria Pezzullo, Cathrine Axfors, Despina G. Contopoulos‐Ioannidis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Angelo Maria Pezzullo, Cathrine Axfors, Despina G. Contopoulos‐Ioannidis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
A Bayesian approach to estimating COVID-19 incidence and infection fatality rates
Justin Slater, Aiyush Bansal, Harlan Campbell, et al.
Biostatistics (2023) Vol. 25, Iss. 2, pp. 354-384
Open Access | Times Cited: 2
Justin Slater, Aiyush Bansal, Harlan Campbell, et al.
Biostatistics (2023) Vol. 25, Iss. 2, pp. 354-384
Open Access | Times Cited: 2
Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium
Serre-Yu Wong, Judith Wellens, Drew Helmus, et al.
Inflammatory Bowel Diseases (2023) Vol. 29, Iss. 11, pp. 1693-1705
Closed Access | Times Cited: 2
Serre-Yu Wong, Judith Wellens, Drew Helmus, et al.
Inflammatory Bowel Diseases (2023) Vol. 29, Iss. 11, pp. 1693-1705
Closed Access | Times Cited: 2
Differential COVID-19 infection rates in children, adults, and elderly: evidence from 38 pre-vaccination national seroprevalence studies
Cathrine Axfors, Angelo Maria Pezzullo, Despina G. Contopoulos‐Ioannidis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Cathrine Axfors, Angelo Maria Pezzullo, Despina G. Contopoulos‐Ioannidis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
SARS-CoV-2 seroprevalence in Nova Scotia blood donors
Sheila F. OʼBrien, Shelley L. Deeks, Todd F. Hatchette, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada (2024) Vol. 9, Iss. 1, pp. 32-45
Open Access
Sheila F. OʼBrien, Shelley L. Deeks, Todd F. Hatchette, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada (2024) Vol. 9, Iss. 1, pp. 32-45
Open Access
Canada’s approach to SARS-CoV-2 sero-surveillance: Lessons learned for routine surveillance and future pandemics
Sheila F. OʼBrien, Michael Asamoah-Boaheng, Brian Grunau, et al.
Can J Public Health (2024) Vol. 115, Iss. 4, pp. 558-566
Closed Access
Sheila F. OʼBrien, Michael Asamoah-Boaheng, Brian Grunau, et al.
Can J Public Health (2024) Vol. 115, Iss. 4, pp. 558-566
Closed Access
Recognising the heterogeneity of Indigenous Peoples during the COVID-19 pandemic: a scoping review across Canada, Australia, New Zealand and the USA
Joonsoo S. Lyeo, Eric N. Liberda, Fatima Ahmed, et al.
BMJ Public Health (2024) Vol. 2, Iss. 2, pp. e001341-e001341
Open Access
Joonsoo S. Lyeo, Eric N. Liberda, Fatima Ahmed, et al.
BMJ Public Health (2024) Vol. 2, Iss. 2, pp. e001341-e001341
Open Access
Sociodemographic characteristics of SARS-CoV-2 serosurveillance studies with diverse recruitment strategies, Canada, 2020 to 2023
Matthew J. Knight, Yuan Yu, Jiacheng Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Matthew J. Knight, Yuan Yu, Jiacheng Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Use of dried blood spots in the detection of coronavirus disease 2019 (COVID-19): A systematic review
Jannie Nikolai M Alquero, Patrizia Marie S Estanislao, Svethlana Marie M Hermino, et al.
Indian Journal of Medical Microbiology (2024) Vol. 51, pp. 100700-100700
Open Access
Jannie Nikolai M Alquero, Patrizia Marie S Estanislao, Svethlana Marie M Hermino, et al.
Indian Journal of Medical Microbiology (2024) Vol. 51, pp. 100700-100700
Open Access
Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021–June 2022
Kelsey M. Sumner, Ruchi Yadav, Emma K. Noble, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Kelsey M. Sumner, Ruchi Yadav, Emma K. Noble, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Two‐phase Bayesian latent class analysis to assess diagnostic test performance in the absence of a gold standard: COVID ‐19 serological assays as a proof of concept
Félix Camirand Lemyre, Sèwanou Hermann Honfo, Chelsea Caya, et al.
Vox Sanguinis (2023) Vol. 118, Iss. 12, pp. 1069-1077
Closed Access | Times Cited: 1
Félix Camirand Lemyre, Sèwanou Hermann Honfo, Chelsea Caya, et al.
Vox Sanguinis (2023) Vol. 118, Iss. 12, pp. 1069-1077
Closed Access | Times Cited: 1
SARS-CoV-2 Omicron Variant Severity in Ontario, Canada—Reply
Ana Cecilia Ulloa, Sarah A. Buchan, Kevin A. Brown
JAMA (2022) Vol. 328, Iss. 4, pp. 395-395
Closed Access | Times Cited: 1
Ana Cecilia Ulloa, Sarah A. Buchan, Kevin A. Brown
JAMA (2022) Vol. 328, Iss. 4, pp. 395-395
Closed Access | Times Cited: 1
